Detailed answers about MEDICAL ASCEND LIMITED, including incorporation, status, business activity, and accounts information.
When was MEDICAL ASCEND LIMITED founded?
MEDICAL ASCEND LIMITED was officially incorporated on 9 July 2024 and is registered under company number SC815878. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is MEDICAL ASCEND LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of MEDICAL ASCEND LIMITED?
MEDICAL ASCEND LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does MEDICAL ASCEND LIMITED do?
MEDICAL ASCEND LIMITED operates in the following sectors: 62012 - Business and domestic software development, 62090 - Other information technology service activities, 85590 - Other education n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is MEDICAL ASCEND LIMITED's registered address?
The registered office address of MEDICAL ASCEND LIMITED is 7E ABBOTSFORD STREET, DUNDEE, SCOTLAND, DD2 1DE. This is the official address filed with Companies House for legal and statutory correspondence.
Is MEDICAL ASCEND LIMITED financially stable?
Financial accounts for MEDICAL ASCEND LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.
Has MEDICAL ASCEND LIMITED changed its name?
Yes, MEDICAL ASCEND LIMITED has had 1 previous name: POCKET PATIENT LIMITED (changed 21 November 2024).